Considering aesthetic surgery?
You need to do your research and become an informed consumer.
Resources / Links
Aesthetic Surgery Books
Information about Anti-Aging Products and Their Active
Read more here
Surgery Celebrity Cosmetic Surgery Whose Had it??
Find out here!
PERRICONE SKIN CARE PRODUCTS
straight from Paris!
HAIRMAX LASER COMB
Second U.S. Patent Issued to Skinvisible for Its Novel Polymer Delivery
(press release from Skinvisible Pharmaceuticals, Inc.)
article sponsored by:
BUY all your Skin Cosmeceuticals here!
Kits, PREVAGE, True Cosmetics, FREEZE 24/7, DR.Brandt Crease Release, Kinerase,
Strivectin, Obagi, Z.Bigatti, M.D. Forte, Dermanew, DDF Wrinkle Relax, Cellex-C,
City Lips, TNS Recovery Complex, FREE SHIPPING, FREE SAMPLES!!
Invisicare(R) which, when topically applied, holds active ingredients on the
skin's surface for up to four hours, resists both wash-off and rub-off,
affording the active agent within the formula an extended period of time to
perform its intended function.
Skinvisible, Inc. (OTC Bulletin Board: SKVI) (Website: www.skinvisible.com), a
topical drug delivery company that out-licenses its family of polymer delivery
vehicles, Invisicare(R), to established developers and manufacturers of
prescription, as well as over-the-counter, dermatological, medical, cosmetic and
skincare products, announced today that it has been issued a second patent by
the U.S. Patent and Trademark Office protecting the 'Polymer Composition' of the
Company's Invisicare(R) polymer delivery system. When topically applied,
Invisicare(R)-formulated products hold active ingredients on the skin for up to
four hours -- thereby affording the active ingredients an extended timeframe to
perform their intended functions.
Previously, a patent was issued to Skinvisible related to the 'Method of
Manufacturing' Invisicare(R). A third patent application, related to 'Methods of
Use' of Invisicare(R), is pending.
"The issuance of this second Invisicare(R) patent protects the unique mechanism
by which we can safely deliver formulated products using Invisicare(R) to remain
on the skin for extended periods of time, resulting in improved efficacy, longer
duration of action, reduced irritation and lower dosage of active agent
required. This patent thus represents another significant milestone for our
company, one that continues to validate the novelty of our technology platform,
Invisicare(R)," said Terry Howlett, President and CEO of Skinvisible.
At the heart of Skinvisible's patented technology and trademarked Invisicare(R)
family of polymer delivery vehicles is its formula and process for combining
hydrophilic and hydrophobic polymers into stable complexes in water emulsions.
This allows formulated products using Invisicare(R) as their platform to remain
on the skin for extended periods of time, thereby affording active agents a
prolonged timeframe to perform their intended functions. Products utilizing
Invisicare(R) have the proven ability to bond active ingredients to the skin for
up to four or more hours. They are non-occlusive and allow normal skin
respiration and perspiration while moisturizing and protecting against exposure
from a wide variety of environmental irritants. When topically applied, these
formulated products adhere to the skin's outer layers, forming a protective
bond, resisting wash-off, and delivering targeted levels of therapeutic or
cosmetic skincare agents to the skin. They allow enhanced delivery performance
for a variety of skincare agents resulting in improved efficacy, longer duration
of action, reduced irritation and lower dosage of active agent required. The
"invisible" polymer compositions wear off as part of the natural exfoliation
process of the skin's outer layer cells.
About Skinvisible Pharmaceuticals, Inc.
Headquartered in Las Vegas, Nevada, Skinvisible Pharmaceuticals is a
research-and-development company that has formulated and patented innovative
polymer delivery system technology and compositions for topical skin
applications. Skinvisible's primary marketing and sales objective is to license
its technology and sell its trademarked polymer delivery vehicles to established
dermatological, cosmetic, skincare and pharmaceutical manufacturers.
This press release contains 'forward-looking' statements within the meaning of
Section 21A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, and are subject to the safe harbors
created thereby. Such statements involve certain risks and uncertainties
associated with an emerging company. Actual results could differ materially from
those projected in the forward looking statements as a result of risk factors
discussed in Skinvisible, Inc. reports on file with the U.S. Securities and
Exchange Commission (including, but not limited to, a report on Form 10QSB for
the quarter ending September 30, 2005).
Contacts: Ronald Trahan, APR, President Terry Howlett, President/CEO Ronald
Trahan Associates Inc., Skinvisible, Inc., 702-433-7154 781-762-9782, x18
SOURCE Skinvisible Pharmaceuticals, Inc.
Ronald Trahan, APR, President of Ronald Trahan Associates Inc., +1-781-762-9782,
ext. 18; or Terry Howlett, President/CEO of Skinvisible, Inc., +1-702-433-7154
Knowledge is Power.
Information is How You Get
Most Popular Facial Skin Cleansing System for 1/2 the price, The LOWEST Price
on the internet!!
HOME LASER HAIR REMOVAL
Created by the same scientists who made in-office laser hair removal a
sale!! Home laser light photo rejuvenation therapy; in the privacy of your home
correct the signs of sun damage, age spots, wrinkles and acne.
Do you want to advertise on this site?
Lopez has revealed her skin care secret!
Mason Pearson Hair Brushes